Cannabinoid Receptor
All Product Categories
-
Cannabinoid Receptor Inhibitors
(21)
View all products
-
Cannabinoid Receptor Agonists
(60)
View all products
-
Cannabinoid Receptor Antagonists
(44)
View all products
-
Cannabinoid Receptor Activators
(9)
View all products
-
Cannabinoid Receptor Modulators
(15)
View all products
-
Cannabinoid Receptor Chemical
(1)
View all products
-
Cannabinoid Receptor Controls
(2)
View all products
-
Cannabinoid Receptor Ligands
(8)
View all products
-
Cannabinoid Receptor Related Products (294)
Related Products (294)
-
Anandamide-d11
0 ImagesSynonyms: AEA-d11
-
S-Methoprene (Standard)
0 ImagesSynonyms: (+)-Methoprene (Standard); (7S)-Methoprene (Standard)2-Methyl-3-(trifluoromethyl)aniline (Standard) is the analytical standard of 2-Methyl-3-(trifluoromethyl)aniline. This product is intended for research and analytical applications. 2-Methyl-3-(trifluoromethyl)aniline is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
-
β-Caryophyllene-13C,d2
0 ImagesCat. No.: HY-N1415S1CAS No.: 3028869-04-4Synonyms: (-)-(E)-Caryophyllene-13C,d2; (−)-β-caryophyllene-13C,d2; (−)-trans-Caryophyllene-13C,d2β-Caryophyllene-13C,d2 is 13C and deuterated labeled β-Caryophyllene (HY-N1415). β-Caryophyllene is a CB2 receptor agonist.
-
CB2 receptor antagonist 1
0 ImagesCat. No.: HY-147707CAS No.: 2772693-05-5Hexyl resorcinol derivative 29 has been proved to be a CB2 selective competitive antagonist / reverse agonist with good potency. Olivanol and 5- (2-methyloctane-2-yl) resorcinol derivatives 23 and 24 showed significant antinociceptive activity. Compound 24 was shown to activate cannabinoid and TRPV1 receptors.
-
Virodhamine TFA
0 ImagesCat. No.: HY-110194CAS No.: 1415264-56-0Virodhamine TFA is an endocannabinoid, it regulates neurotransmission by activating the cannabinoid (CB) receptors. Virodhamine is an antagonist of CB1 receptor and an agonist of CB2 receptor. Virodhamine TFA induces megakaryocytic differentiation by triggering MAPK signaling and ROS production. Virodhamine TFA can be used for the research of various neurological disorders such as Alzheimer's and Parkinson's diseases.
-
Palmitoyl serinol-d5
0 ImagesCat. No.: HY-125407SCAS No.: 946524-35-2Synonyms: N-Palmitoyl serinol-d5Palmitoyl serinol-d5 is the deuterium labeled Palmitoyl serinol. Palmitoyl serinol (N-Palmitoyl serinol) is an analog of the endocannabinoid N-palmitoyl ethanolamine (PEA). Palmitoyl serinol improves the epidermal permeability barrier in both normal and inflamed skin.
-
O-1269
0 ImagesCat. No.: HY-167865CAS No.: 336615-64-6O-1269 is a partial agonist of cannabinoid receptor 1 (CB1R) with a Ki of 32 nM. O-1269 shows analgesic effects.
-
CB-52
0 ImagesCat. No.: HY-121545CAS No.: 869376-90-9CB-52 is the ligand and neutral antagonist of CB2 cannabinoid receptor.
-
11(Z),14(Z)-Eicosadienoic acid ethanolamide
0 ImagesCat. No.: HY-169038CAS No.: 162758-92-111(Z),14(Z)-Eicosadienoic acid ethanolamide (Compound 3) is an ethanolamide-conjugated form of 11(Z),14(Z)-Eicosadienoic acid (HY-149589). 11(Z),14(Z)-Eicosadienoic acid ethanolamide inhibits the inactivating transport of an endogenous cannabinoid substance with an IC50 value of 10.6 μM. 11(Z),14(Z)-Eicosadienoic acid ethanolamide can be used for research of neuropsychiatric conditions.
-
CB2 receptor antagonist 3
0 ImagesCat. No.: HY-155481CB2 receptor antagonist 3 (compound (S)-1) is an inverse agonist of the cannabinoid receptor CB2R with Kd=39 nM. CB2 receptor antagonist 3 can be used as a tool to synthesize a variety of CB2R probes.
-
BPR-890
0 ImagesCat. No.: HY-14140CAS No.: 1170700-86-3BPR-890 is a potent agonist of CB1. BPR-890 exhibits excellent CB2/1 selectivity and has in vivo efficacy in diet-induced obese mouse model.
-
OLHHA
0 ImagesCat. No.: HY-139230CAS No.: 1258011-97-0OLHHA is a dual CB1 receptor antagonist and PPARα agonist. OLHHA also is a alcohol intake inhibitor with an EC50 value of 0.2 mg/kg. OLHHA reduces both hepatic lipid accumulation and circulating triglyceride levels. OLHHA shows anti-steatotic activity and has the potential for the research of non-alcoholic fatty liver disease (NAFLD).
-
APP-FUBINACA
0 ImagesCat. No.: HY-118245CAS No.: 1185282-03-4APP-FUBINACA is a cannabinoid receptor agonist and a derivative of phenylalaninamide-based indazole-3-carboxamide. APP-FUBINACA exhibits neurostimulatory effects.
-
HU 433
0 ImagesCat. No.: HY-W751734CAS No.: 1220887-84-2
-
JTE 7-31
0 ImagesCat. No.: HY-122281CAS No.: 194358-72-0JTE 7-31 selectively acts on peripheral cannabinoid receptors, minimizing central nervous system side effects. They exhibit potent immunomodulatory, anti-inflammatory and anti-allergic properties, as well as inhibitory effects on nephritis.
-
CB2 receptor antagonist 5
0 ImagesCat. No.: HY-116380CAS No.: 1314230-69-7
-
CB2 receptor agonist 7
0 ImagesCat. No.: HY-14160CAS No.: 871819-90-8
-
AM404-d4
0 ImagesCat. No.: HY-W777527CAS No.: 1185244-71-6AM404-d4 is the deuterium labeled AM404 (HY-101388). AM404, an inhibitor of endocannabinoid reuptake, blocks anandamide transport with IC50 values in the low micromolar range. AM404 is able to relax rat isolated hepatic arteries contracted with Phenylephrine, with a pEC50 value of 7.4 (corresponding to an EC50 of 0.04 μM). Neuroprotective Effect.
-
CB1R/AMPK modulator 1
0 ImagesCat. No.: HY-155967CAS No.: 2711012-08-5
